JPH0728725B2 - New microorganism - Google Patents
New microorganismInfo
- Publication number
- JPH0728725B2 JPH0728725B2 JP8248586A JP8248586A JPH0728725B2 JP H0728725 B2 JPH0728725 B2 JP H0728725B2 JP 8248586 A JP8248586 A JP 8248586A JP 8248586 A JP8248586 A JP 8248586A JP H0728725 B2 JPH0728725 B2 JP H0728725B2
- Authority
- JP
- Japan
- Prior art keywords
- strain
- acid
- bacillus
- medium
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】 本発明は、好アルカリ性のバシラス属に属する新規な微
生物に関する。更に詳しくは、本発明は、 一般式(I) (式中、Rは低級アルキル基を示す。Bzlはベンジル基
を示す。) で示されるシス−イミダゾリジンジカルボン酸ジエステ
ル類(以下ジエステル類と略称する。)を一般式(II) (式中、Rは低級アルキル基を示す。Bzlはベンジル基
を示す。4位、5位の配位は4S、5Rの配位である。) で示される光学活性なシス−イミダゾリジンジカルボン
酸誘導体(以下、ハーフエステル類と略称する。)に変
換する能力を有する新規な好アルカリ性のバシラス・エ
スピー VA−62株(微工研菌寄第8729)を提供するもの
である。The present invention relates to a novel microorganism belonging to the alkalophilic Bacillus genus. More specifically, the present invention relates to general formula (I) (In the formula, R represents a lower alkyl group and Bzl represents a benzyl group.) The cis-imidazolidinedicarboxylic acid diesters (hereinafter abbreviated as diesters) represented by the general formula (II) (In the formula, R represents a lower alkyl group. Bzl represents a benzyl group. The 4-position and 5-position are 4S and 5R coordinates.) Optically active cis-imidazolidinedicarboxylic acid The present invention provides a novel alkaline basophilus Bacillus sp. Strain VA-62 strain (Ministry of Industrial Science, Microbiology Co. No. 8729) having the ability to convert to a derivative (hereinafter referred to as half ester).
一般式(I)および(II)において低級アルキル基とは
メチル、エチル、n−プロピル、イソプロピル、n−ブ
チル、t−ブチル、n−ペンチル、n−ヘキシル基等の
C1〜C6アルキル基を意味する。In the general formulas (I) and (II), the lower alkyl group includes methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, n-pentyl, n-hexyl groups and the like.
Means C 1 -C 6 alkyl group.
本発明によって得られる光学活性ハーフエステル類(I
I)はビチオンおよびその他医薬品の合成中間体とて極
めて重要な化合物である。従来、微生物による光学活性
ハーフエステル類(II)の製造方法としては、クロモバ
クテリウム(Chromobacterium)属によるもの(特開昭5
8−190395)しか知られていなかった。The optically active half-esters (I
I) is a very important compound as a synthetic intermediate for biotin and other pharmaceuticals. Conventionally, as a method for producing optically active half-esters (II) by microorganisms, a method based on the genus Chromobacterium has been disclosed (Japanese Patent Application Laid-Open No. 5-312058).
Only 8-190395) was known.
そこで本発明者らは、ジエステル類(I)を光学活性ハ
ーフエステル類(II)に変換する能力を有する微生物を
広く自然界に検索した。その結果好アルカリ性のバシラ
ス(Bacillus)属に属する微生物の中に係る能力を有す
るものがあることを見い出し、本発明を完成するに至っ
た。Therefore, the present inventors extensively searched for microorganisms having the ability to convert diesters (I) into optically active half esters (II) in nature. As a result, they have found that some of the microorganisms belonging to the alkalophilic Bacillus genus have such ability, and completed the present invention.
以下、本発明の微生物を詳細に説明する。Hereinafter, the microorganism of the present invention will be described in detail.
VA−62株の菌学的性質は、次のとおりである。The mycological properties of the VA-62 strain are as follows.
(a) 形態的性質(肉汁寒天培地及び肉汁培地) (b) 各種培地における生育形態 (c) 生理学的性質 以上の菌学的性質に示されたように、VA−62株は、好気
的条件下に生育する有胞子性桿菌であることからバージ
ェイズ・マニュアル・オブ・デターミネイティブ・バク
テリオロジー(Bergey's Manual of Determinative Bac
teriology)第8版の検索式に従いバシラス属に属する
ことは、明らかである。さらにVA−62株と同属中の菌種
を比較すると、類似菌株としてバシラス・ブレビス(Ba
cillus brevis)及びバシラス・アルカロフィラス(Bac
illus alkalophilus)があげられるが、バシラス・ブレ
ビスは、生育の最適温度が40〜60℃でスターチ加水分解
力がなく、耐塩性もNaCl5%以下である点でVA−62株と
は異なる。バシラス・アルカロフィラスは、アルカリ性
の培地でのみ生育する点がVA−62株と同じであるが、ふ
くらみを持った胞子のうを形成せず、硝酸塩の還元能も
ない点でVA−62株とは異なる。(A) Morphological properties (broth agar medium and broth medium) (B) Growth form in various media (C) Physiological properties As shown in the above bacteriological properties, the VA-62 strain is a spore-forming bacillus that grows under aerobic conditions, and therefore, the Barjays Manual of Determinative Bacteriology (Bergey's Manual of Determinative Bac
teriology) Obviously, it belongs to the genus Bacillus according to the search formula of the 8th edition. Furthermore, comparing the strains of the same genus with the VA-62 strain, Bacillus brevis (Ba
cillus brevis) and Bacillus alcalophilus (Bac
illus alkalophilus), but Bacillus brevis differs from the VA-62 strain in that the optimum temperature for growth is 40 to 60 ° C., it has no starch hydrolyzing power, and its salt tolerance is 5% or less NaCl. Bacillus alcalophilus is the same as the VA-62 strain in that it grows only in an alkaline medium, but it does not form a swelling spore with swelling and has no nitrate reducing ability, so it is different from the VA-62 strain. different.
以上のことから、本発明者らは、VA−62株をバシラス属
に属する好アルカリ性の新菌種と認め、バシラス・エス
ピー VA−62と命名した。本菌株は、工業技術院微生物
工業技術研究所に受託番号微工研菌寄第8729号として寄
託されている。From the above, the present inventors recognized the VA-62 strain as a new alkalophilic strain belonging to the genus Bacillus and named it Bacillus sp. VA-62. This strain has been deposited at the Institute of Microbial Science and Technology, the Agency of Industrial Science and Technology, under the deposit number Microindustrial Research Institute No. 8729.
本発明に係る微生物は、上記の菌学的性質における特徴
のほか、ジエステル類(I)の存在下で培養することに
より培地中に多量の光学活性ハーフエステル類(II)を
蓄積する点でも特徴づけられる。また、当該微生物に紫
外線、X線、γ線等の照射、化学変異処理剤、ファージ
接触、形質転換、形質導入、接合による遺伝子組換、細
胞融合による遺伝子組換、プラスミドによる遺伝子導入
などの変異処理を施して得られる人工変異株もしくは自
然変異株を包含する。The microorganism according to the present invention is characterized in that, in addition to the above-mentioned characteristics in mycological properties, it is accumulated in the medium in a large amount by culturing in the presence of diesters (I). Be attached. In addition, mutations such as irradiation of the microorganism with ultraviolet rays, X-rays, γ-rays, chemical mutation treatment agents, phage contact, transformation, transduction, gene recombination by conjugation, gene recombination by cell fusion, and gene introduction by plasmids. The artificial mutants or natural mutants obtained by the treatment are included.
本発明に用いられる微生物を培養する培地としては、通
常行われる微生物の培養に常用される炭素源と窒素源、
無機物等を含む各種の培地を使用することができる。培
地の炭素源としては、たとえばグルコース、フラクトー
ス、シュクロース、デンプン、グリセリン、糖蜜などの
炭水化物、グルコン酸、ピルビン酸、酢酸、クエン酸、
などの有機酸類、グリシン、グルタミン酸、アラニン、
アスパラギンなどのアミノ酸類、n−パラフィンなどの
炭化水素類などである。窒素源としてはたとえば肉エキ
ス、ペプトン、酵母エキス、乾燥酵母、味液、大豆粉、
ないしはその加水分解物、カゼイないしその加水分解
物、各種アミノ酸、各種アンモニウム塩、硝酸塩などで
ある。無機物の例は、リン酸塩、あるいはマグネシウ
ム、カリウム、カルシウム、ナトリウム、鉄、マンガン
などの塩類である。The medium for culturing the microorganism used in the present invention includes a carbon source and a nitrogen source that are commonly used for culturing microorganisms that are usually used,
Various media containing inorganic substances and the like can be used. Examples of the carbon source of the medium include glucose, fructose, sucrose, starch, glycerin, molasses and other carbohydrates, gluconic acid, pyruvic acid, acetic acid, citric acid,
Organic acids such as, glycine, glutamic acid, alanine,
Examples include amino acids such as asparagine and hydrocarbons such as n-paraffin. Examples of the nitrogen source include meat extract, peptone, yeast extract, dry yeast, taste liquid, soybean powder,
Or hydrolysates thereof, casei or hydrolysates thereof, various amino acids, various ammonium salts, nitrates and the like. Examples of inorganic substances are phosphates or salts of magnesium, potassium, calcium, sodium, iron, manganese and the like.
培養は通常好気的に行われ、振とう培養あるいは通気撹
はん培養が好適である。培養日数は、通常半日から7日
間が適当である。培養温度は、微生物が増殖し、ジエス
テル類(I)を光学活性ハーフエステル類(II)に変換
できる温度であれば特に制限はないが、通常20〜30℃が
好ましく、培養液pHは、8〜10が好ましい。Culturing is usually carried out aerobically, and shaking culture or aeration-agitation culture are preferred. The appropriate number of days for culture is usually from half a day to 7 days. The culture temperature is not particularly limited as long as the microorganism can grow and convert the diesters (I) into the optically active half esters (II), but it is preferably 20 to 30 ° C., and the culture solution pH is 8 -10 is preferable.
本菌株の培養により光学活性ハーフエステル類(II)を
得るには、生育の当初からあるいは後にジエステル類
(I)を培養液に添加し、培養を継続し、半加水分解を
行わせる方法が最も簡便である。基質濃度は0.1〜10%
程度が適当である。培養物中に蓄積された光学活性ハー
フエステル類(I)を単離精製するには、有機化合物の
単離精製に通常用いられる単離精製手段を適用すればよ
い。The best way to obtain optically active half-esters (II) by culturing this strain is to add diesters (I) to the culture solution from the beginning or after the growth, continue the culture, and carry out semi-hydrolysis. It's simple. Substrate concentration is 0.1-10%
The degree is appropriate. In order to isolate and purify the optically active half-esters (I) accumulated in the culture, the isolation and purification means usually used for the isolation and purification of organic compounds may be applied.
光学活性ハーフエステル類(II)はまた本菌株の培養液
から遠心分離またはろ過等により集菌した微生物細胞を
用いて半加水分解する方法、あるいは微生物の細胞から
超音波処理、リゾチーム処理等により酵素を遊離させ冷
却下遠心分離、硫安分画、沈殿透析等により耐アルカリ
性のエステラーゼを得てこれを用いて半加水分解する方
法にても実施できる。これらの場合には、ジエステル類
(I)を好ましくはpH8〜10に調製した水溶液又は緩衝
溶液にけん濁するか溶解し、ジエステル類(I)に対し
て微生物の細胞もしくは耐アルカリ性のエステラーゼを
好ましくは0.001〜0.1重量比添加し、好ましくは10〜40
℃で撹はんすることにより反応が進行し、通常1時間〜
数日間で反応が終了する。The optically active half-esters (II) can also be subjected to semi-hydrolysis by using microbial cells collected from the culture solution of this strain by centrifugation or filtration, or by sonication or lysozyme treatment of the cells of the microorganism. It is also possible to carry out a method in which an alkali-resistant esterase is obtained by liberating the product by centrifugation under cooling, ammonium sulfate fractionation, precipitation dialysis and the like, and using this to perform semi-hydrolysis. In these cases, the diesters (I) are preferably suspended or dissolved in an aqueous solution or a buffer solution prepared to have a pH of 8 to 10, and microbial cells or an alkaline esterase resistant to the diesters (I) are preferred. Is added 0.001 to 0.1 weight ratio, preferably 10 to 40
The reaction proceeds by stirring at ℃, usually 1 hour ~
The reaction ends in a few days.
上述、水溶液とは硫酸、塩酸、リン酸等の鉱酸、酢酸、
クエン酸等の有機酸、水酸化ナトリウム、水酸化カリウ
ム、炭酸ナトリウム等の無機塩基、トリエチルアミン、
ピリジン等の有機塩基、酢酸ナトリウム、塩化ナトリウ
ム等の塩を添加した水溶液を意味する。As mentioned above, the aqueous solution is sulfuric acid, hydrochloric acid, mineral acid such as phosphoric acid, acetic acid
Organic acids such as citric acid, inorganic bases such as sodium hydroxide, potassium hydroxide and sodium carbonate, triethylamine,
It means an aqueous solution to which an organic base such as pyridine and a salt such as sodium acetate and sodium chloride are added.
緩衝溶液とは、リン酸二水素カリウム・水酸化ナトリウ
ム、リン酸二水素カリウム・リン酸一水素ナトリウム、
フタル酸水素カリウム・塩酸、グリシン・塩化ナトリウ
ム・水酸化ナトリウム等の一般的緩衝溶液を意味し、反
応を妨げるもの以外は特に制限はない。The buffer solution is potassium dihydrogen phosphate / sodium hydroxide, potassium dihydrogen phosphate / sodium monohydrogen phosphate,
It means a general buffer solution such as potassium hydrogen phthalate / hydrochloric acid, glycine / sodium chloride / sodium hydroxide, etc., and there is no particular limitation as long as it does not interfere with the reaction.
又、必要に応じメタノール、エタノール、n−プロパノ
ール、イソプロパノール、n−ブタノール、t−ブタノ
ールの如きアルコール系溶媒、エーテル、テトラヒドロ
フラン、ジオキサンの如きエーテル系溶媒、ベンゼン、
トルエン等の芳香族炭化水素系溶媒、アセトン、メチル
エチルケトン、ジエチルケトン等のケトン系溶媒、トリ
エチルアミン、ピリジン等のアミン系溶媒、ジメチルホ
ルムアミド、ジメチルスルホキシド等の極性溶媒、又、
ソルビタンモノパルミテート、ソルビタンモノラウレー
ト等の如き界面活性剤を添加する事もできる。If necessary, an alcohol solvent such as methanol, ethanol, n-propanol, isopropanol, n-butanol, t-butanol, an ether solvent such as ether, tetrahydrofuran, dioxane, benzene,
Aromatic hydrocarbon solvents such as toluene, acetone, methyl ethyl ketone, ketone solvents such as diethyl ketone, amine solvents such as triethylamine and pyridine, polar solvents such as dimethylformamide, dimethyl sulfoxide, etc.,
Surfactants such as sorbitan monopalmitate and sorbitan monolaurate can also be added.
以下に実施例をもって本発明をさらに詳細に説明する
が、本発明はこれらにより限定されないことは勿論のこ
とである。Hereinafter, the present invention will be described in more detail with reference to Examples, but it goes without saying that the present invention is not limited thereto.
実施例1 (バシラス・エスピー・VA−62株の分離) 兵庫県宝塚市で採取した土壌サンプルの小スパーテル1
杯分(約0.5g)を10mlの滅菌生理食塩水にけん濁し、充
分撹はんした後放置する。この土壌けん濁液上清約0.5m
lをシス−1、3−ジベンジル−2−オキソイミダゾリ
ン−4、5−ジカルボン酸ジメチルエステル含有の分離
用培地(表1)10mlに添加する。28℃で4日間振とう培
養した後、0.5mlを新しい同分離用培地10mlに接種し同
様に培養する。この操作を3回繰り返す。最終の培養試
料を滅菌生理食塩水にて適当な菌数まで希釈し、このも
のの1滴を上記分離用培地に寒天を2%になるように加
えた分離寒天培地を塗抹する。28℃で4日間培養した後
生じたコロニーをさらに同分離用寒天培地を用いて分離
を繰り返し、完全に純化したものをVA−62株とした。こ
の菌株の菌学的性質は前述の通りである。Example 1 (Separation of Bacillus sp. VA-62 strain) Small spatula 1 of soil sample collected in Takarazuka City, Hyogo Prefecture
Suspend 1 cup (about 0.5 g) in 10 ml of sterilized physiological saline, stir it thoroughly, and let it stand. About 0.5m of this soil suspension supernatant
l is added to 10 ml of separating medium (Table 1) containing cis-1,3-dibenzyl-2-oxoimidazoline-4,5-dicarboxylic acid dimethyl ester. After culturing with shaking at 28 ° C. for 4 days, 0.5 ml of the same is inoculated into 10 ml of the same medium for separation, and cultivated in the same manner. This operation is repeated 3 times. The final culture sample is diluted with sterile physiological saline to an appropriate number of bacteria, and 1 drop of this is smeared on a separation agar medium in which agar is added to the above-mentioned separation medium so that the content of agar is 2%. Colonies generated after culturing at 28 ° C. for 4 days were further separated using the same agar medium for separation, and completely purified to obtain VA-62 strain. The mycological properties of this strain are as described above.
次いで本菌株を利用して(4S,5R)−1、3−ジベンジ
ル−5−メトキシカルボニル−2−オキソイミダゾリジ
ン−4−カルボン酸を採取した例を参考例としてあげ
る。Next, an example in which (4S, 5R) -1,3-dibenzyl-5-methoxycarbonyl-2-oxoimidazolidine-4-carboxylic acid was collected using this strain will be given as a reference example.
参考例1) 可溶性デンプン1g、酵母エキス0.5g、ペプトン0.5g、K2
HPO4 0.1g、MgSO4・7H2O 0.02g、CuSO4・5H2O 0.0005
g、MnCl4・4H2O 0.0005g、ZnSO4・7H2O 0.0001g、FeSO4
・7H2O 0.0002g、蒸溜水100mlからなる溶液を希水酸化
ナトリウムにてpH9.0に調整した。 Reference Example 1) Soluble starch 1 g, yeast extract 0.5 g, peptone 0.5 g, K 2
HPO 4 0.1g, MgSO 4 · 7H 2 O 0.02g, CuSO 4 · 5H 2 O 0.0005
g, MnCl 4 / 4H 2 O 0.0005g, ZnSO 4 / 7H 2 O 0.0001g, FeSO 4
A solution of 0.0002 g of 7H 2 O and 100 ml of distilled water was adjusted to pH 9.0 with diluted sodium hydroxide.
この液体培地を120℃にて20分間滅菌した後、バシラス
・エスピー(Bacilus sp.)VA−62株を接種し、28℃で4
8時間振とう培養した。これにシス−1、3−ジベンジ
ル−2−オキソイミダゾリジン−4、5−カルボン酸ジ
メチルエステル400mgを添加した後、さらに28℃で72時
間振とう反応させた。This liquid medium was sterilized at 120 ° C for 20 minutes, and then inoculated with Bacilus sp. VA-62 strain, and at 4 ° C at 28 ° C.
It was shake-cultured for 8 hours. After adding 400 mg of cis-1,3-dibenzyl-2-oxoimidazolidine-4,5-carboxylic acid dimethyl ester thereto, the mixture was further shake-reacted at 28 ° C. for 72 hours.
この反応液に酢酸エチル100mlを加え、希塩酸にて酸性
とした後、セライトろ過した。ろ液を分液し、有機溶媒
層を水にて洗浄後、無水硫酸マグネシウムにて乾燥し減
圧濃縮した。残さに5%重そう水20mlを加え、溶解後エ
ーテル20mlにて洗浄し、分液した。100 ml of ethyl acetate was added to this reaction solution, which was acidified with diluted hydrochloric acid, and then filtered through Celite. The filtrate was separated, the organic solvent layer was washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. To the residue was added 20% of 5% heavy sodium hydroxide water, and after dissolution, the mixture was washed with 20 ml of ether and separated.
水層を希硫酸にてpH2とし、析出した白色結晶をろ過
し、水にて洗浄後乾燥した。(4S、5R)−1、3−ジベ
ンジル−5−メトキシカルボニル−2−オキソイミダゾ
リジン−4−カルボン酸が、320mg得られた。The aqueous layer was adjusted to pH 2 with diluted sulfuric acid, the precipitated white crystals were filtered, washed with water and dried. 320 mg of (4S, 5R) -1,3-dibenzyl-5-methoxycarbonyl-2-oxoimidazolidine-4-carboxylic acid was obtained.
融点 149〜151℃ ▲〔α〕20 365▼ −28.0゜(C=1、DMF) であった。The melting point was 149 to 151 ° C ▲ [α] 20 365 ▼ -28.0 ° (C = 1, DMF).
Claims (1)
テル類を、光学活性はシス−イミダゾリジンジカルボン
酸誘導体に変換する能力を有する、バシラス・エスピー
VA−62株(微工研菌寄第8729号)1. Bacillus sp. Which has an optical activity of converting cis-imidazolidinedicarboxylic acid diesters into cis-imidazolidinedicarboxylic acid derivatives.
VA-62 strain (Microtechnology Research Institute, Microbiology No. 8729)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8248586A JPH0728725B2 (en) | 1986-04-10 | 1986-04-10 | New microorganism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8248586A JPH0728725B2 (en) | 1986-04-10 | 1986-04-10 | New microorganism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62239985A JPS62239985A (en) | 1987-10-20 |
| JPH0728725B2 true JPH0728725B2 (en) | 1995-04-05 |
Family
ID=13775813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8248586A Expired - Fee Related JPH0728725B2 (en) | 1986-04-10 | 1986-04-10 | New microorganism |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0728725B2 (en) |
-
1986
- 1986-04-10 JP JP8248586A patent/JPH0728725B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62239985A (en) | 1987-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5886093A (en) | Biological preparation of amide | |
| US4774179A (en) | Process for preparing a 7-aminocephalosporanic acid compound | |
| US4353987A (en) | Process for preparing glyceraldehyde from glycerol with methanol dehydrogenase | |
| US4764606A (en) | 7-formylaminocephalosporin compounds | |
| CZ282337B6 (en) | Micro-organisms of pseudomonas strain and process of microbiological production of s-alpha-aminocarboxylic acids and amides of r-alpha-aminocarboxylic acids | |
| JPH0728724B2 (en) | New microorganism | |
| US5273893A (en) | Microbiological process for the production of hydroxypyrazinecarboxylic acid | |
| JPH0728725B2 (en) | New microorganism | |
| JPH0673464B2 (en) | Process for producing optically active cis-imidazolidinedicarboxylic acid derivative | |
| US4010072A (en) | Process for preparing L-tartaric acid | |
| EP0206595B1 (en) | Thermally stable tryptophanase process for producing the same, and thermally stable tryptophanase-producing microorganism | |
| JPH05336979A (en) | Production of p-hydroxybenzoic acid | |
| US5496715A (en) | Process for preparing indigo | |
| JP3514799B2 (en) | Lipase and microorganism producing the same | |
| JP2786500B2 (en) | Production method of optically active 1,3-butanediol | |
| JPH0640829B2 (en) | Method for producing indoleacetic acid | |
| JP3055711B2 (en) | Method for producing optically active (S) -3-phenyl-1,3-propanediol | |
| JP2964163B2 (en) | Method for producing R (-)-1,3-butanediol | |
| JPH08168389A (en) | Method for producing organic secretion using cyanobacteria | |
| JP3789234B2 (en) | Method for producing 6-hydroxypicolinic acid | |
| JP3090761B2 (en) | Production method of optically active lactic acid | |
| JPH08275776A (en) | Novel chitinase and method for producing the same | |
| JPH07188A (en) | Novel microorganism and method for producing D-malic acid using the same | |
| JPH04304894A (en) | Production of hydroxide of picolinic acid or pyrazinic acid by microorganism | |
| JP2715260B2 (en) | New green algae, new yeast, and method for producing 2,6-naphthalenedicarboxylic acid using the green algae or the yeast |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |